ALK Immunohistochemistry and Molecular Analysis in Uterine Inflammatory Myofibroblastic Tumor: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting-Reference-Cited by-同舟云学术

ALK Immunohistochemistry and Molecular Analysis in Uterine Inflammatory Myofibroblastic Tumor: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting

Published:2020-12-08 Issue:1 Volume:40 Page:28-31
ISSN:0277-1691
Container-title:International Journal of Gynecological Pathology
language:en
Short-container-title:

Author:

Parra-Herran Carlos

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology,Pathology and Forensic Medicine

Reference28 articles.

1. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors;Rabban;Am J Surg Pathol,2005

2. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course;Parra-Herran;Am J Surg Pathol,2015

3. Inflammatory Myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad histologic spectrum;Bennett;Mod Pathol,2017

4. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract;Fuehrer;Arch Pathol Lab Med,2012

5. ALK-rearranged tumors are highly enriched in the STUMP subcategory of uterine tumors;Devereaux;Am J Surg Pathol,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory myofibroblastic tumor of the uterus: A rare case report of misdiagnosis as cystic degenerated uterus leiomyoma;Asian Journal of Surgery;2024-06

2. Uterine inflammatory myofibroblastic tumor with myxoid predominance: diagnostic challenge;International Journal of Gynecologic Cancer;2024-04-19

3. Advances in uterine inflammatory myofibroblastic tumours: Diagnostic challenges and risk stratification;Histopathology;2024-04-17

4. The “Other” Uterine Mesenchymal Neoplasms: Recent Developments and Emerging Entities;Advances in Anatomic Pathology;2024-04-16

5. Uncommon Uterine Mesenchymal Neoplasms and Mixed Epithelial-Mesenchymal Lesions;Gynecologic and Obstetric Pathology;2024